Abstract
HERPES-LIKE virus (HLV) similar to that first detected in cultured Burkitt lymphoma1 cells was subsequently demonstrated in many other human leucocyte cell lines2–5. Although no readily applicable bioassay is available for HLV, in vitro transformation of normal human leucocytes was demonstrated by co-cultivation with X-irradiated Burkitt lymphoma cells6 and by inoculation of filtrates of leucocyte lines of leukaemic7 and Burkitt lymphoma8 origin, and some evidence was presented that this transformation was caused by HLV. The presence of HLV in a small proportion of cultured cells has usually been demonstrated either directly by electron microscopy1 or indirectly by immunofluorescence (IF) tests9–11. In human sera, complement-fixing (CF) antibody to crude antigens of leucocyte cell lines containing HLV is associated with IF antibody, suggesting some relationship between HLV and the CF antigen9,12. Virion13 and soluble12 components contributed to the activity of several CF antigens studied so far.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Epstein, M. A., Achong, B. G., and Barr, Y. M., Lancet, i, 702 (1964).
Moore, G. E., Grace, J. T., Citron, P., Gerner, R., and Burns, A., NY St. J. Med., 66, 2757 (1966).
Diehl, V., Henle, G., Henle, W., and Kohn, G., J. Virol., 2, 663 (1968).
Moore, G. E., Gerner, R. E., and Franklin, H. A., J. Amer. Med. Assoc., 199, 519 (1967).
Gerber, P., and Monroe, J. H., J. Nat. Cancer Inst., 40, 855 (1968).
Henle, W., Diehl, V., Kohn, G., zur Hausen, H., and Henle, G., Science., 157, 1064 (1967).
Pope, J. H., Horne, M. K., and Scott, W., Intern. J. Cancer, 3, 857 (1968).
Pope, J. H., Horne, M. K., and Scott, W., Intern. J. Cancer (in the press).
Henle, G., and Henle, W., J. Bact., 91, 1248 (1966).
zur Hausen, H., Henle, W., Hummeler, K., Diehl, V., and Henle, G., J. Virol., 1, 830 (1967).
Epstein, M. A., and Achong, B. G., J. Nat. Cancer Inst., 40, 593 (1968).
Armstrong, D., Henle, G., and Henle, W., J. Bact., 91, 1257 (1966).
Gerber, P., and Birch, S. M., Proc. US Nat. Acad. Sci., 58, 478 (1967).
Pope, J. H., Achong, B. G., Epstein, M. A., and Biddulph, J., J. Nat. Cancer Inst., 39, 933 (1967).
Epstein, M. A., and Achong, B. G., J. Nat. Cancer Inst., 40, 609 (1968).
Pope, J. H., Austral. J. Exp. Biol. Med. Sci., 46, 643 (1968).
Pope, J. H., Nature, 216, 810 (1967).
Pulvertaft, R. J. V., J. Clin. Pathol., 18, 261 (1965).
Epstein, M. A., Achong, B. G., Barr, Y. M., Zajac, B., Henle, G., and Henle, W., J. Nat. Cancer Inst., 37, 547 (1966).
Herberman, R. B., and Fahey, J. L., Proc. Soc. Exp. Biol. and Med., 127, 938 (1968).
Black, P. H., Rowe, W. P., Turner, H. C., and Huebner, R. J., Proc. US Nat. Acad. Sci., 50, 1148 (1963).
Habel, K., Virology, 25, 55 (1965).
Huebner, R. J., Rowe, W. P., Turner, H. C., and Lane, W. T., Proc. US Nat. Acad. Sci., 50, 379 (1963).
Huebner, R. J., Armstrong, D., Okuyan, M., Sarma, P. S., and Turner, H. C., Proc. US Nat. Acad. Sci., 51, 742 (1964).
Hartley, J. W., Rowe, W. P., Capps, W. I., and Huebner, R. J., Proc. US Nat. Acad. Sci., 53, 931 (1965).
Rowe, W. P., in Cross-reacting Antigens and Neoantigens (with Implications for Autoimmunity and Cancer Immunity) (edit. by Trentin, J. J.), 74 (The Williams and Wilkins Co., Baltimore, 1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
POPE, J., HORNE, M. & WETTERS, E. Significance of a Complement-fixing Antigen associated with Herpes-like Virus and detected in the Raji Cell Line. Nature 222, 186–187 (1969). https://doi.org/10.1038/222186a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/222186a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.